Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time?

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time?

As targeted molecular therapies and immuno-oncology have become pivotal in the management of patients with lung cancer, the essential requirement for high throughput analyses and clinical validation of biomarkers has become even more intense, with response rates maintained in the 20%⁻30% r...

Full description

Bibliographic Details
Main Authors: Paul Hofman, Cécile Badoual, Fiona Henderson, Léa Berland, Marame Hamila, Elodie Long-Mira, Sandra Lassalle, Hélène Roussel, Véronique Hofman, Eric Tartour, Marius Ilié
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Cancers
Subjects:
multiplexed
brightfield
chromogenic
fluorescence
molecular
immune profiling
immune-oncology
digital
lung cancer
Online Access:https://www.mdpi.com/2072-6694/11/3/283

Internet

https://www.mdpi.com/2072-6694/11/3/283

Similar Items